ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Transcatheter Aortic Valve Replacement (TAVR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-15W12910
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Transcatheter Aortic Valve Replacement TAVR Sales Market Report 2023
BUY CHAPTERS

Transcatheter Aortic Valve Replacement (TAVR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-15W12910
Report
August 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Edwards Lifesciences
Medtronic Inc
Abbott
Boston Scientific
Meril Life Sciences
VENUS MEDTECH
Bracco (HLT)
Jenavalve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort

Transcatheter Aortic Valve Replacement (TAVR)- Market Size

The global market for Transcatheter Aortic Valve Replacement (TAVR) was estimated to be worth US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 17790 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.

Transcatheter Aortic Valve Replacement (TAVR)- Market

Transcatheter Aortic Valve Replacement (TAVR)- Market

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcatheter Aortic Valve Replacement (TAVR) by region & country, by Type, and by Application.
The Transcatheter Aortic Valve Replacement (TAVR) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Replacement (TAVR).
Market Segmentation

Scope of Transcatheter Aortic Valve Replacement (TAVR)- Market Report

Report Metric Details
Report Name Transcatheter Aortic Valve Replacement (TAVR)- Market
Forecasted market size in 2031 US$ 17790 million
CAGR 10.8%
Forecasted years 2025 - 2031
Segment by Type
  • Transfemoral Approach
  • Transapical Approach
  • Others
Segment by Application
  • Aortic Stenosis
  • Aortic Regurgitation
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, MicroPort
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Transcatheter Aortic Valve Replacement (TAVR)- Market size in 2031?

Ans: The Transcatheter Aortic Valve Replacement (TAVR)- Market size in 2031 will be US$ 17790 million.

What is the market share of major companies in Transcatheter Aortic Valve Replacement (TAVR)- Market?

Ans: Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%

Who are the main players in the Transcatheter Aortic Valve Replacement (TAVR)- Market report?

Ans: The main players in the Transcatheter Aortic Valve Replacement (TAVR)- Market are Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, MicroPort

What are the Application segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR)- Market report?

Ans: The Applications covered in the Transcatheter Aortic Valve Replacement (TAVR)- Market report are Aortic Stenosis, Aortic Regurgitation, Others

What are the Type segmentation covered in the Transcatheter Aortic Valve Replacement (TAVR)- Market report?

Ans: The Types covered in the Transcatheter Aortic Valve Replacement (TAVR)- Market report are Transfemoral Approach, Transapical Approach, Others

1 Market Overview
1.1 Transcatheter Aortic Valve Replacement (TAVR) Product Introduction
1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast (2020-2031)
1.3 Transcatheter Aortic Valve Replacement (TAVR) Market Trends & Drivers
1.3.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
1.3.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers & Opportunity
1.3.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
1.3.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Ranking (2024)
2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
2.3 Key Companies Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Transcatheter Aortic Valve Replacement (TAVR) Product Offered
2.5 Key Companies Time to Begin Mass Production of Transcatheter Aortic Valve Replacement (TAVR)
2.6 Transcatheter Aortic Valve Replacement (TAVR) Market Competitive Analysis
2.6.1 Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Transfemoral Approach
3.1.2 Transapical Approach
3.1.3 Others
3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type
3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Type (2020-2031)
3.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Aortic Stenosis
4.1.2 Aortic Regurgitation
4.1.3 Others
4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application
4.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Application (2020-2031)
4.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region
5.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2020-2025)
5.1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2026-2031)
5.1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
5.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
5.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
5.4.2 Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
5.5.2 South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
5.6.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.3 United States
6.3.1 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.3.2 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.4.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.5.2 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.6.2 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.7.2 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.8.2 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020-2031
6.9.2 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Profile
7.1.2 Edwards Lifesciences Main Business
7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.1.5 Edwards Lifesciences Recent Developments
7.2 Medtronic
7.2.1 Medtronic Profile
7.2.2 Medtronic Main Business
7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.2.5 Medtronic Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.3.5 Abbott Recent Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Profile
7.4.2 Boston Scientific Main Business
7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.4.5 Boston Scientific Recent Developments
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Profile
7.5.2 Meril Life Sciences Main Business
7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.5.5 Meril Life Sciences Recent Developments
7.6 Venus Medtech
7.6.1 Venus Medtech Profile
7.6.2 Venus Medtech Main Business
7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.6.5 Venus Medtech Recent Developments
7.7 Bracco (HLT)
7.7.1 Bracco (HLT) Profile
7.7.2 Bracco (HLT) Main Business
7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.7.5 Bracco (HLT) Recent Developments
7.8 JenaValve Technology
7.8.1 JenaValve Technology Profile
7.8.2 JenaValve Technology Main Business
7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.8.5 JenaValve Technology Recent Developments
7.9 Suzhou Jiecheng Medical Technology Co.
7.9.1 Suzhou Jiecheng Medical Technology Co. Profile
7.9.2 Suzhou Jiecheng Medical Technology Co. Main Business
7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
7.10 Peijia Medical
7.10.1 Peijia Medical Profile
7.10.2 Peijia Medical Main Business
7.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.10.5 Peijia Medical Recent Developments
7.11 MicroPort
7.11.1 MicroPort Profile
7.11.2 MicroPort Main Business
7.11.3 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
7.11.4 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2020-2025)
7.11.5 MicroPort Recent Developments
8 Industry Chain Analysis
8.1 Transcatheter Aortic Valve Replacement (TAVR) Industrial Chain
8.2 Transcatheter Aortic Valve Replacement (TAVR) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transcatheter Aortic Valve Replacement (TAVR) Sales Model
8.5.2 Sales Channel
8.5.3 Transcatheter Aortic Valve Replacement (TAVR) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Edwards Lifesciences
Medtronic Inc
Abbott
Boston Scientific
Meril Life Sciences
VENUS MEDTECH
Bracco (HLT)
Jenavalve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort
List of Tables
 Table 1. Transcatheter Aortic Valve Replacement (TAVR) Market Trends
 Table 2. Transcatheter Aortic Valve Replacement (TAVR) Market Drivers & Opportunity
 Table 3. Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
 Table 4. Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
 Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Transcatheter Aortic Valve Replacement (TAVR) Product Type
 Table 9. Key Companies Time to Begin Mass Production of Transcatheter Aortic Valve Replacement (TAVR)
 Table 10. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2020-2025) & (%)
 Table 27. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2026-2031) & (US$ Million)
 Table 31. Edwards Lifesciences Basic Information List
 Table 32. Edwards Lifesciences Description and Business Overview
 Table 33. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Edwards Lifesciences (2020-2025)
 Table 35. Edwards Lifesciences Recent Developments
 Table 36. Medtronic Basic Information List
 Table 37. Medtronic Description and Business Overview
 Table 38. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Medtronic (2020-2025)
 Table 40. Medtronic Recent Developments
 Table 41. Abbott Basic Information List
 Table 42. Abbott Description and Business Overview
 Table 43. Abbott Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Abbott (2020-2025)
 Table 45. Abbott Recent Developments
 Table 46. Boston Scientific Basic Information List
 Table 47. Boston Scientific Description and Business Overview
 Table 48. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Boston Scientific (2020-2025)
 Table 50. Boston Scientific Recent Developments
 Table 51. Meril Life Sciences Basic Information List
 Table 52. Meril Life Sciences Description and Business Overview
 Table 53. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Meril Life Sciences (2020-2025)
 Table 55. Meril Life Sciences Recent Developments
 Table 56. Venus Medtech Basic Information List
 Table 57. Venus Medtech Description and Business Overview
 Table 58. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Venus Medtech (2020-2025)
 Table 60. Venus Medtech Recent Developments
 Table 61. Bracco (HLT) Basic Information List
 Table 62. Bracco (HLT) Description and Business Overview
 Table 63. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Bracco (HLT) (2020-2025)
 Table 65. Bracco (HLT) Recent Developments
 Table 66. JenaValve Technology Basic Information List
 Table 67. JenaValve Technology Description and Business Overview
 Table 68. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of JenaValve Technology (2020-2025)
 Table 70. JenaValve Technology Recent Developments
 Table 71. Suzhou Jiecheng Medical Technology Co. Basic Information List
 Table 72. Suzhou Jiecheng Medical Technology Co. Description and Business Overview
 Table 73. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Suzhou Jiecheng Medical Technology Co. (2020-2025)
 Table 75. Suzhou Jiecheng Medical Technology Co. Recent Developments
 Table 76. Peijia Medical Basic Information List
 Table 77. Peijia Medical Description and Business Overview
 Table 78. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of Peijia Medical (2020-2025)
 Table 80. Peijia Medical Recent Developments
 Table 81. MicroPort Basic Information List
 Table 82. MicroPort Description and Business Overview
 Table 83. MicroPort Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Transcatheter Aortic Valve Replacement (TAVR) Business of MicroPort (2020-2025)
 Table 85. MicroPort Recent Developments
 Table 86. Key Raw Materials Lists
 Table 87. Raw Materials Key Suppliers Lists
 Table 88. Transcatheter Aortic Valve Replacement (TAVR) Downstream Customers
 Table 89. Transcatheter Aortic Valve Replacement (TAVR) Distributors List
 Table 90. Research Programs/Design for This Report
 Table 91. Key Data Information from Secondary Sources
 Table 92. Key Data Information from Primary Sources
 Table 93. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Product Picture
 Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2020-2031) & (US$ Million)
 Figure 4. Transcatheter Aortic Valve Replacement (TAVR) Report Years Considered
 Figure 5. Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2024
 Figure 7. Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Transfemoral Approach Picture
 Figure 9. Transapical Approach Picture
 Figure 10. Others Picture
 Figure 11. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 12. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value Market Share by Type, 2024 & 2031
 Figure 13. Product Picture of Aortic Stenosis
 Figure 14. Product Picture of Aortic Regurgitation
 Figure 15. Product Picture of Others
 Figure 16. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Transcatheter Aortic Valve Replacement (TAVR) Sales Value Market Share by Application, 2024 & 2031
 Figure 18. North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value (2020-2031) & (US$ Million)
 Figure 19. North America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
 Figure 20. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 21. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
 Figure 22. Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Region (%), 2024 VS 2031
 Figure 24. South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 25. South America Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
 Figure 26. Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 27. Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Country (%), 2024 VS 2031
 Figure 28. Key Countries/Regions Transcatheter Aortic Valve Replacement (TAVR) Sales Value (%), (2020-2031)
 Figure 29. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 30. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 31. United States Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 32. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 34. Europe Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 35. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 36. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 37. China Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 38. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 40. Japan Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 41. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 42. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 43. South Korea Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 44. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 46. Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 47. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value, (2020-2031) & (US$ Million)
 Figure 48. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Type (%), 2024 VS 2031
 Figure 49. India Transcatheter Aortic Valve Replacement (TAVR) Sales Value by Application (%), 2024 VS 2031
 Figure 50. Transcatheter Aortic Valve Replacement (TAVR) Industrial Chain
 Figure 51. Transcatheter Aortic Valve Replacement (TAVR) Manufacturing Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Transcatheter Aortic Valve Replacement Service Market Research Report 2024
Global Transcatheter Aortic Valve Implantation TAVI Market Insights Forecast to 2030
Global Transcatheter Heart Valve Therapies Market Research Report 2024
Global Cerebral Embolic Protection Devices for TAVI Market Research Report 2025
Transcatheter Aortic Valve Replacement Tubing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Tricuspid Valve Replacement TTVR Technology Market Research Report 2024
Global Transcatheter Aortic Valve Market Research Report 2024
Global Transcatheter Tricuspid Valve Replacement TTVR and Transcatheter Tricuspid Valve Repair TTVr Market Research Report 2024
Global Tanscatheter Mitral Valve Repair and Replacement Market Insights Forecast to 2030
Global Transcatheter Mitral Valve Replacement TMVR Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Transcatheter Heart Valve Replacement and Repair Market Insights Forecast to 2030
Global Transcatheter Aortic Valve Implantation TAVI System Market Research Report 2025
Global Aortic Valve Device Market Research Report 2025
Transcatheter Pulmonary Valve Replacement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aortic Valve Products Market Research Report 2025
Global Transcatheter Aortic Valve System Market Research Report 2025
Global Valvular Disease Interventional Device Market Research Report 2025
Global Transcatheter Aortic Heart Valve Device Market Research Report 2024
Global Transcathetar Devices Market Research Report 2024
Global Valvular Disease Device Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions